ROCK2-IN-10
ROCK2-IN-10 is a potent and selective ROCK2 inhibitor (IC50 = 0.020 μM) with 41-fold selectivity over isoform ROCK1. ROCK2-IN-10 inhibits metastasis by disrupting the cytoskeleton, independent of proliferative suppression. ROCK2-IN-10 shows superior inhibitory potency against cancer cell metastasis, which closely related to the suppression of STAT3 phosphorylation. ROCK2-IN-10 can be used for breast cancer metastasis research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C32H38N8O3
- Masse moléculaire:582.70
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
ROCK2 0.020 μM (IC50) |
ROCK1 0.821 μM (IC50) |
In Vitro
ROCK2-IN-10 (compound S9) derives its excellent potency against ROCK2 from the hydrogen bonds formed by its acetylamino chain with Asp218 and Asn219[1].
ROCK2-IN-10 (5 μM, 24 h) disrupts the overall morphology of MDA-MB-231 cells, resulting in blunted filopodia and discontinuous F-actin stress fibers along the cell contour[1].
ROCK2-IN-10 (2.5-5 μM, 0-48 h) exhibits potent, dose-dependent inhibition of cell migration in MDA-MB-231 cells, and demonstrates significantly greater efficacy than Belumosudil (HY-15307) at both 24 h and 48 h[1].
ROCK2-IN-10 (2.5-5 μM, 24 h) downregulates phosphorylation of STAT3 in a dose-dependent manner, contributing to a promising anti-metastasis efficacy against MDA-MB-231 cells[1].
ROCK2-IN-10 (72 h) exhibits minimal cytotoxicity in MDA-MB-231 cells with an IC50 of 12.77 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MDA-MB-231 cells
-
Concentration:2.5 and 5 μM
-
Incubation Time:24 h
-
Result:Decreased p-STAT3 to nearly half of the control group at the concentration of 5 μM.
Reduced p-STAT3 levels in MDA-MB-231 cells in a dose-dependent manner.
-
Cell Line:MDA-MB-231 cells
-
Concentration:2.5 and 5 μM
-
Incubation Time:0, 24 and 48 h
-
Result:Inhibited the migration of MDA-MB-231 cells, reducing wound closure to 9.65 % after 24 h, compared to 24.51 % in the control group.
Exhibited stronger inhibition than Belumosudil at 5 μM after 24 h, with cell migration rates of 3.48 % compared to 4.74 %.
Maintained a more prominent anti-metastatic effect than Belumosudil at 5 μM after 48 h, with cell migration rates of 9.33 % compared to 12.43 %.
Chemical Information
-
Masse moléculaire 582.70
-
Formule C32H38N8O3
-
SMILES
CC(C=C1)=CC=C1NC(OC[C@H](CCC2)N2C3=NC(NC4=CC5=C(C=C4)NN=C5)=CC=C3NC(CNC6CCCC6)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Orthotopic Cell-Line Xenograft
Orthotopic cell-line xenograft models involve implantation of human cancer cell lines into the anatomically corresponding organ of immunodeficient mice to reproduce tumor growth within a native microenvironment, enabling more clinically relevant tumor behavior compared with subcutaneous models. These models are widely used because orthotopic placement better recapitulates tumor progression, including invasion and metastatic spread, which are often underrepresented in heterotopic implantation systems. Compared with conventional xenografts, orthotopic implantation is described as more technically complex but provides improved simulation of tumor-microenvironment interactions and metastatic behavior, making it particularly valuable for translational oncology research. Surgical orthotopic implantation approaches have been emphasized as enabling faithful reproduction of clinical cancer features, including metastasis and disease progression patterns that align with the tumor’s organ of origi
-
Phalloidin F-actin cytoskeleton staining
Phalloidin F-actin staining detects polymerized filamentous actin in fixed and permeabilized specimens by using fluorescent phalloidin or phalloidin-derived phallotoxins that bind actin filaments and generate a fluorescence microscopy readout corresponding to F-actin organization, including stress fibers, cortical actin, filament bundles, and tissue-specific actin networks. Phalloidin stabilizes F-actin by reducing actin subunit dissociation from filament ends, and fluorescent phallotoxins were established as tools for visualizing actin-containing structures in eukaryotic cells.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)